USA SHIPPEDFREE SHIPPING ON ORDERS OVER $300≥99% PURITY - HPLC + MASS SPECENDOTOXIN TESTED · STERILITY VERIFIEDCOA CERTIFIED · EVERY BATCH TESTEDRESEARCH USE ONLY
USA SHIPPEDFREE SHIPPING ON ORDERS OVER $300≥99% PURITY - HPLC + MASS SPECENDOTOXIN TESTED · STERILITY VERIFIEDCOA CERTIFIED · EVERY BATCH TESTEDRESEARCH USE ONLY
Selank 10mg peptide vial
Cognitive series

Selank 10mg

A synthetic heptapeptide analogue of the immunomodulatory peptide tuftsin, developed for neuropeptide research. 99%+ purity, U.S. lab tested.

99%+ PURITYAH-SELANK-10In stock
$29.99

Bundle & save

Select a quantity. Savings apply automatically.

Up to 5% off
1
Certificate ships with the vial — lot-matched COA, chromatogram, handling sheet.
Held at −20 °C — pulled once, packed with coolant sized to transit.
Order before 2pm — leaves cold storage the same working day.

Selank is a synthetic heptapeptide built on the tuftsin fragment Thr-Lys-Pro-Arg, with a Pro-Gly-Pro tail added to slow enzymatic breakdown. Published work has examined its interaction with GABAergic signalling, BDNF expression and behavioural models of anxiety.

Specification

Written On The Vial.

Lot-matched certificate ships with every vial
SEQUENCEThr-Lys-Pro-Arg-Pro-Gly-Pro
MOLECULAR FORMULAC33H57N11O9
MOLECULAR WEIGHT751.9 g/mol
CAS NUMBER129954-34-3
PRESENTATIONLyophilised powder, sealed vial
STORAGE-20 °C sealed · 2-8 °C reconstituted
SOLUBILITYBacteriostatic water
Also in the range

Related Products.

All compounds
Access confirmation

Before you enter.

AminoHaus supplies compounds strictly for in-vitro laboratory research and analytical reference use by qualified professionals.

  • Laboratory research onlyFor in-vitro research and analytical reference use.
  • No human or veterinary useNot for consumption, administration, food, or drug manufacture.
  • No medical purposeNot intended to diagnose, treat, cure, or prevent any condition.

The complete research-use disclaimer remains available in the site footer. Acceptance applies only to this browser session; you'll confirm again next session.

Stay close to the record.

New compound releases and certificate updates—delivered to your inbox.